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ABSTRACT
Regeneration of peripheral nerve injury remains a major clinical challenge. Recently, mesenchymal
stem cells (MSCs) have been considered as potential candidates for peripheral nerve regeneration;
however, the underlying mechanisms remain elusive. Here, we show that human gingiva-derived
MSCs (GMSCs) could be directly induced intomultipotent NPCs (iNPCs) underminimally manipulated
conditions without the introduction of exogenous genes. Using a crush-injury model of rat sciatic
nerve, we demonstrate that GMSCs transplanted to the injury site could differentiate into neuronal
cells, whereas iNPCs could differentiate into both neuronal and Schwann cells. After crush injury,
iNPCs, compared with GMSCs, displayed superior therapeutic effects on axonal regeneration at both
the injury site and the distal segment of the injured sciatic nerve. Mechanistically, transplantation of
GMSCs, especially iNPCs, significantly attenuated injury-triggered increase in the expression of c-Jun,
a transcription factor that functions as a major negative regulator of myelination and plays a central
role in dedifferentiation/reprogramming of Schwann cells into a progenitor-like state. Meanwhile,
our results also demonstrate that transplantation of GMSCs and iNPCs consistently increased the ex-
pression of Krox-20/EGR2, a transcription factor that governs the expression of myelin proteins and
facilitatesmyelination. Altogether, our findings suggest that transplantation ofGMSCs and iNPCs pro-
motes peripheral nerve repair/regeneration, possibly by promoting remyelination of Schwann cells
mediated via the regulation of the antagonistic myelination regulators, c-Jun and Krox-20/EGR2.
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SIGNIFICANCE
Fully functional recovery of injured peripheral nerve remains a major clinical challenge. Stem cell-
based therapy is emerging as a novel paradigm for peripheral nerve regeneration. Neural stem (or
progenitor) cells (NSCs) are considered an ideal candidate seed cell source for nerve regeneration,
but it remains a challenge to obtain enough transplantable NSCs for clinical application. This report
shows that humangingiva-derivedmesenchymal stemcells (GMSCs) canbeeasily induced intoneural
progenitor-like cells (iNPCs). Importantly, the results strongly suggest thatGMSCs, particularlyGMSC-
derived iNPCs, promote peripheral nerve regeneration, possibly by regulating the expression of the
antagonistic myelination regulators c-Jun and Krox-20/EGR2 in Schwann cells in rat sciatic nerves.
INTRODUCTION
Injuries to the peripheral nervous system (PNS)
are debilitating and usually lead to considerable
long-term disability as a result of loss of nerve
and end-organ target functions [1]. Even though
the endogenous repair process is initiated after
nerve injury, intrinsic regenerative capability is
rather limited, especially when there is a large
gap between the damaged nerve stumps [2, 3].
In the last decade, even though significant effort
has been made to develop various types of bio-
engineered nerve grafts to facilitate peripheral
nerve regeneration [2], the overall clinical out-
comes still remain suboptimal [4]. Recently, there
has been growing enthusiasm for the use of stem
cell-oriented tissue engineering technologies to
facilitate regeneration of injured peripheral nerves.
Among various types of stem cells, NSCs are con-
sidered an ideal seed candidate for cell-based
treatment of nerve injury and neurodegenera-
tive diseases; however, it remains a challenge
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to generate enough transplantable NSCs for clinical application.
Alternatively, other types of adult stem cells, particularly mesen-
chymal stem cells (MSCs) isolated from different tissues such as
bone marrow [5–9], adipose tissue [10–15], skeletal muscle [16,
17], anddental pulp [18–21], also confer properties to transdiffer-
entiate into neuronal and glial progenies and produce neurotro-
phic factors, serving as relevant sources for stem cell-based
therapy in peripheral nerve injury (PNI) [12, 14, 19–22]. However,
the high heterogeneity, limited and variable neural differentia-
tion and survival abilities, unpredictable cell fate, and variation
of clinical outcomes significantly hinder the clinical application
of MSCs in peripheral nerve regeneration.
Expandable and multipotent neural progenitor cells (NPCs)
can be generated from embryonic stem cells and induced plurip-
otent stem cells (iPSCs), but the process is complicated and time-
consuming and raises safety concerns in clinical application [23].
Recently, it has been shown that different types of somatic cells
could be directly induced into expandable NPCs by overexpress-
ing certain transcriptional factors [24–30]. Interestingly, somatic
cells, including fibroblasts andMSCs, can also be directly induced
into multipotent NPC-like cells by small-molecule compounds or
under specific growth conditions without introducing exoge-
nous transcription factors [11, 31–35]. Such novel nongenetic
approaches to generate conditionally induced NPC-like cells
may hold great promise for autologous NPC-based therapy of
peripheral nerve regeneration.
Repair of the injured peripheral nerve depends on the plastic-
ity of Schwann cells, theglial cells of thePNS. In response to injury,
Schwann cells can dedifferentiate, proliferate, phagocytose mye-
lin debris, and release a myriad of chemokines and cytokines to
recruit immune cells to the injured nerve and neurotrophic fac-
tors to support neuron survival and promote axon regrowth
[36–38]. The reversible transition between dedifferentiation
andmyelination status of Schwann cells is orchestrated by a com-
plex cross-antagonistic network of transcriptional regulators,
whereby the zinc finger transcription factor Krox-20/EGR2 gov-
erns the expression of a set of myelination-related genes, and
the transcription factor c-Jun, anegative regulator ofmyelination,
plays a crucial role in the dedifferentiation of Schwann cells
[38–40]. The contribution of stem cells to peripheral nerve regen-
erationmay involve their role in Schwann cell transdifferentiation
[14, 15] and paracrine neurotrophic and angiogenic effects
[12, 20, 22], but little is known about the underlying mechanisms
of stem cell-mediated regulation of dedifferentiation and myeli-
nation of Schwann cells in injured peripheral nerves.
We have recently isolated a unique subpopulation of multipo-
tentMSCs fromhumangingiva(GMSCs) that isofneural crestorigin,
is highly proliferative, and possesses potent immunomodulatory
functionsandneurogenicdifferentiationpotential [41–44].Thepur-
pose of thepresent study is to adopt nongeneticmethods to induce
multipotent and expandableNPC-like cells fromhumanGMSCs and
explore the feasibility of regenerative stem cell treatment in PNI.
Compellingly, GMSC-derived NPC-like cells (iNPCs) could differenti-
ate into neuronal and Schwann cells both in vitro and in vivo.More
importantly, using a crush-injury rat sciatic nerve model, we dem-
onstrate that perineural transplantation of iNPCs promotes
Schwann cell and axonal regeneration at both the injury and distal
segments of the injured nerve. Mechanistically, GMSCs and iNPCs
significantly increased the expression of myelination regulatory
gene Krox-20/EGR2 and concomitantly suppressed the expression
of dedifferentiation regulatory protein c-Jun. This study provided
the first line of evidence that GMSCs could be transiently converted
into multipotent iNPCs under specific culture conditions and that
these unique iNPCs are capable of promoting peripheral nerve re-
generation, possibly by regulating the dedifferentiation and myeli-
nation of Schwann cells.
MATERIALS AND METHODS
Animals
Female Sprague-Dawley rats weighing 200–250 g (6–7weeks old)
were obtained fromCharles River Laboratories (Wilmington,MA,
http://www.criver.com). All animal procedures were handled
according to the guidelines of the Institutional Animal Care and
Use Committee of the University of Pennsylvania. We adopted
a randomized, prospective, controlled animal model design
according to all the recommendations of the Animal Research:
Reporting In Vivo Experiments (ARRIVE) guidelines. Rats were
group-housed in polycarbonate cages (two animals per cage) in
the animal facilities with controlled temperature (23°C 6 2°C),
40%–65%humidity, and 12-hour light/dark cycle. Ratswere accli-
matized for at least 1 week before the study, fed with a standard
laboratory diet, and allowed ad libitum access to drinking water.
In Vitro Induction of iNPCs From Human GMSCs
Gingival tissues were obtained as remnants of discarded tissues
under the approved Institutional Review Board protocol at the
University of Pennsylvania. The isolation and characterization
of human gingival tissue-derivedMSCswere described previously
[41]. To induce NPC-like cells from GMSCs, adherent monolayer
GMSCs were trypsinized and seeded onto poly-L-ornithine/
laminin-treated 6-well plates (2 3 105 cells/well) and cultured
with complete a-minimum essential medium for 24 hours. The
medium was replaced with neural cell culture medium (neuro-
basal medium supplemented with 1% N-2 Supplement, 1%
B27, 100 U/ml penicillin, 100 mg/ml streptomycin, and 550 mM
2-mercaptoethanol; all from Thermo Fisher Scientific Life Sci-
ences, Waltham, MA, http://www.thermofisher.com), 20 ng/ml
epidermal growth factor (EGF) and 20 ng/ml basic fibroblast
growth factor (bFGF) (PeproTech, Rocky Hill, NJ, http://www.
peprotech.com). Under this condition, neurosphere formation
was observed at approximately 3–6 days. The neurospheres were
completelydissociated intosinglecellsusingStemProAccutaseCell
Dissociation Reagent (Thermo Fisher), and cell viability was deter-
mined by Trypan blue staining. Dissociated cells were seeded onto
polyornithine/laminin-precoated dishes for further culture.
In Vitro Neural Differentiation
GMSC-derived NPC-like cells at passages 3–4 were seeded on
poly-D-lysine- and laminin-coated plastic coverslips (Nunc) and
cultured in neurobasal medium supplemented with 1% N-2 Sup-
plement, 5% fetal bovine serum, 0.5 mM all-trans-retinoic acid
(Sigma-Aldrich, St. Louis, MO, http://www.sigmaaldrich.com),
and 10 ng/ml brain-derived neurotrophic factor (PeproTech)
for neuronal differentiation [33]. For Schwanncell differentiation,
cells were cultured in regular MSC culturemedium supplemented
with35ng/mlall trans-retinoic acid for 72hours. Themediumwas
changed to regular culturemedium supplementedwith 5mMfor-
skolin (Sigma-Aldrich), 10 ng/ml bFGF, 5 ng/ml platelet-derived
growth factor AA, and 200 ng/ml heregulin-b-1 (PeproTech)
[14, 19]. Themediumwas replenishedevery3days. After2weeks,
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cells were prepared for immunocytofluorescence studies to ex-
amine the expression of neuronal or glial cell markers.
Immunofluorescence Staining
Cells fixedwith 4% paraformaldehyde were blocked and permea-
bilized for 1 hour at room temperature in PBS, 2.5% goat serum,
and 0.5% Triton X‐100, followed by incubation with the following
primary antibodies at the appropriate dilution overnight at 4°C:
Oct-4 (mouse IgG, 1:250, sc5279; Santa Cruz Biotechnology, Santa
Cruz, CA, http://www.scbt.com), Sox1 (rabbit IgG, 1:250, ab109290;
Abcam, Cambridge, MA, http://www.abcam.com), Pax6 (rabbit
IgG, 1:250, GTX113241; GeneTex, Irvine, CA, http://www.genetex.
com),Nestin (mouse IgG,1:250,MAB5326; EMDMillipore, Billerica,
MA, http://www.emdmillipore.com), Vimentin (mouse IgG, 1:300,
sc73528; SantaCruzBiotechnology),b-tubulin III (mouse IgG, 1:250,
MCA2047; Bio-Rad, Hercules, CA, http://www.bio-rad.com), and
S-100b (rabbit IgG, 1:250, ABN59; EMD Millipore). After washing
with PBS, cells were incubatedwith appropriate secondary antibodies
at room temperature for 1 hour: goat antirabbit IgG-fluorescein iso-
thiocyanate (FITC) (1:250, sc2012; Santa Cruz Biotechnology), goat
antirabbit IgG-rhodamine (1:250, sc2091; Santa Cruz Biotechnol-
ogy), goat antimouse IgG-FITC (1:250, sc-2010; Santa Cruz Biotech-
nology), and goat antimouse IgG-rhodamine (1:250, sc2092; Santa
Cruz Biotechnology). Isotype-matched control antibodies (BioLegend,
San Diego, CA, http://www.biolegend.com) were used as negative
controls. Nuclei were counterstained with 49,6-diamidino-2-
phenylindole (DAPI). Images were captured using an Olympus
inverted fluorescence microscope (IX73) (Olympus Corporation of
the Americas, Center Valley, PA, http://www.olympusamerica.com).
For semiquantitative analysis, cells with positive signals in at least
six randomhigh-power fieldswerevisualized, counted, andexpressed
as thepercentageof total DAPI-positive cells [41]. For flowcytometric
analysis, intracellular immunostaining of Nestin, Sox-1, Pax-6, and
Vimentin in cells was performed using nuclear factor fixation, perme-
abilization, and staining buffer sets according to manufacturer’s pro-
tocols (BioLegend). After immunostaining, cells were resuspended
in 0.5 ml cell staining buffer and analyzed with a FACSCalibur (BD
Biosciences, San Jose, CA, http://www.bdbiosciences.com).
Western Blot Analysis
Cell or sciatic nerve tissue lysates were separated on sodium
dodecyl sulfate-polyacrylamide gel and electroblottedonto nitro-
cellulose membrane (Bio-Rad). After blocking with Tris-buffered
saline/5% nonfat drymilk, themembranewas incubatedwith an-
tibodies against Oct-4, Sox-1, Pax-6, Vimentin,b-tubulin III, S100-
b, KROX20/EGR2 (Bioss Antibodies, Woburn, MA, http://www.
biossusa.com), and c-Jun (BDBiosciences) followed by incubation
with a horseradish peroxidase-conjugated secondary antibody,
and the signals were visualized by enhanced chemiluminescence
detection (Santa Cruz Biotechnology). The blots were also re-
probed with a specific antibody against b-actin (Sigma-Aldrich).
Enzyme-Linked Immunosorbent Assay
The concentrationofbrain-derivedneurotrophic factor, glial-derived
neurotrophic factor (GDNF), nerve growth factor-b, neurotrophin 3,
vascular endothelial growth factor (VEGF), and interleukin-6 in con-
ditionedmedia fromGMSCs, three-dimensional (3D)-spheroids, and
iNPCsweredetectedusingenzyme-linked immunosorbent assay kits
according to themanufacturer’s protocols (ScienCell Research Labo-
ratories, Carlsbad, CA, http://wwwsciencellonline.com).
Crush Injury of Rat Sciatic Nerve and
Cell Transplantation
Female Sprague-Dawley rats were anesthetized by intraperito-
neal injection of a mixture of ketamine/xylazine (100/10 mg/kg
body weight). An incision was made from the right sciatic notch
to the distal thigh, and the subcutaneous tissue was bluntly dis-
sected to expose the bicep femoris muscle. The sciatic nerve
was exposed and crushed at a point 1 mm distal to the sciatic
nerve bifurcation with a type 5 watchmaker forceps for 30 sec-
onds as previously described [14, 45]. A combinatorial cell-
scaffold product was developed using PKH26-prelabeled GMSCs
or iNPCs (23 105 cells) seeded on GelFoam (63 43 3 mm). Im-
mediately after nerve crush injury, the cell-scaffold product was
transplanted and wrapped around the injury site of the nerve
structure. Rats with sciatic nerve injury and transplanted with
GelFoam alone served as control groups. At different time points
after nerve injury and cell transplantation, animals were sacri-
ficed and sciatic nerves were harvested for further analysis
(supplemental online Fig. 4A).
Histological and Immunohistochemical Studies
The gastrocnemius muscles of both hindlimbs were harvested 4
weeks after surgery and weighed. The sciatic nerves were fixed
in 4% paraformaldehyde for 24 hours, cryoprotected in 10%,
20%, and 30% sucrose, and embedded in optimal cutting temper-
ature medium, and 10-mm-thick cryostat sections were cut. After
blocking and permeabilization in PBS + 3% bovine serum albumin
+ 0.5%Triton X‐100 at room temperature for 1 hour, the sections
were incubated with primary antibodies for b-tubulin III (1:250)
or S-100b (1:250) overnight at 4°C, followed by incubation with
FITC-conjugated secondary antibodies for 1 hour at room temper-
ature. Isotype-matched control antibodies (BioLegend) were used
as negative controls. Nuclei were counterstained with DAPI. The
integrated immunofluorescence density of a region of interest
was quantified using ImageJ (National Institutes of Health), and
the corrected total cryosection fluorescence was calculated as av-
erage of integrated density2 (average of selected areas3mean
fluorescence of background), as previously described [46].
Statistical Analysis
Differences between experimental and control groups were ana-
lyzed by paired Student’s t test. One-way analysis of variance was
used to test the statistical significance of multiple group differ-
ences, unless otherwise indicated. Post hoc pairwise comparison
between individual groups was made using the Tukey test.
p values less than .05 were considered statistically significant.
SPSS software was used for all the analyses. All data were ex-
pressed as mean6 SE.
RESULTS
Induction of NSC-Related Genes in GMSCs
We first examined the expression of NSC-related genes [33] in ad-
herent GMSCs cultured as a monolayer under neural induction
conditions. Immunofluorescence staining showed that exposure
of GMSCs to the neurobasal medium supplemented with 1%
N-2 Supplement, 2% B27, 20 ng/ml EGF, and 20 ng/ml bFGF for
3 days significantly upregulated the expression of Nestin, Sox-1,
Pax-6, and Vimentin compared with regular culture conditions
Zhang, Nguyen, Xu et al. 3
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(Fig. 1A–1C). The proportion of NSC-positive cells, specifically
Nestin+ cells, increased from 5.74% to 42.7%, Sox-1+ cells in-
creased from 8.44% to 28.06%, Pax-6+ cells increased from
8.98% to 64.64%, and Vimentin+ cells increased from 28.88% to
84.6% (Fig. 1D). In addition, Western blot analysis further con-
firmed a time-dependent increase in the expression of these
NSC-related genes in GMSCs,which peaked by day 3 under neural
culture conditions (Fig. 1E). These results suggest that GMSCs
have the potential to be converted into NSC-like cells under neu-
ral induction conditions.
We then determined the expression of NSC-related genes
in GMSCs under 3D-spheroid culture exposed to neural induc-
tion conditions. The cells spontaneously aggregated into
3D-spheroid structures with positive 5-bromo-29-deoxyuridine
incorporation, suggesting their proliferating status (supplemental
online Fig. 1A). Immunostaining showed elevated expression of
NSC-related genes, such as Nestin, Sox-1, Pax-6, and Vimentin
(supplemental online Fig. 1B–1D).Quantitatively, flowcytometric
analysis of 3D-spheroid GMSCs confirmed the enhanced ex-
pression of neural differentiation markers, specifically a mark-
edly increase in the proportion of Nestin+ cells from 3.2% to
37.8%, Sox-1+ cells from 5.6% to 22.4%, and Pax-6+ cells from
2.7% to 30.8%, compared with the regular adherent GMSCs
(supplemental online Fig. 1E). The increased expression of
NSC-related genes in spheroid GMSCs was further confirmed
by Western blot analysis (supplemental online Fig. 1F), show-
ing the time-dependent expression of these gene products.
These results suggest that 3D-spheroid culture can enhance
NSC-related gene expressions in GMSCs.
Induction of NPCs From GMSCs
We then tested whether 3D-spheroid neural culture could
promote the induction of NPC-like properties in GMSCs. After
suspension culture for 6 days, 3D spheroids were com-
pletely dissociated into single cells (Fig. 2A), and cell viability
analysis showed that more than 90% of them stayed viable
(supplemental online Fig. 1G). Morphologically, these cells
became smaller and relatively homogeneous in size and
formed uniform and compact colonies (Fig. 2A). Upon subcul-
ture, the cells dissociated from the colonies could reform
neurospheres and compact colonies under suspension and ad-
herent culture conditions, respectively (Fig. 2B). Immunofluo-
rescence staining showed that the majority of cells within the
Figure 1. Increasedexpressionofneural stemcell-relatedgenes inGMSCscultured inneuralmedium.GMSCswere cultured inneurobasalmedium
supplementedwith1%N-2Supplement, 2%B27,20ng/mlEGF,and20ng/mlbFGF fordifferent timeperiods. (A–C): Immunofluorescencestudieson
theexpressionofNestin, SOX1, PAX6, andVimentin. Nucleiwere counterstainedwithDAPI (blue). Scale bars = 20mm(340). (D):Percentage of cells
positive for eachmarker.pp,p, .01. (E):Westernblotanalysis of theexpressionofNestin, SOX1, PAX6, andVimentin; graph showsdensities relative
tob-actin as the internal control. Abbreviations: bFGF, basic fibroblast growth factor; DAPI, 49,6-diamidino-2-phenylindole; EGF, epidermal growth
factor; GMSC, gingiva-derived mesenchymal stem cell N-GMSC, neural culture of gingiva-derived mesenchymal stem cell.
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colonies were positive for Nestin, Sox-1, Pax-6, and Vimentin
(Fig. 2C, 2D). Flow cytometric analysis showed that almost
100%of the induced cellswere positive forNestin andVimentin,
whereas ∼80% of the induced cells were positive for Sox-1 and
Pax-6 (Fig. 2E). Western blot analysis confirmed the increased
expression of these NSC-related genes in induced GMSCs in
comparison with noninduced and spheroid GMSCs (Fig. 2F).
In addition, our results showed that 3D-spheroid cells and iNPCs
secreted a higher level of GDNF and VEGF than the parental
GMSCs (supplemental online Fig. 2).
Next, we tested whether the resultant cells possessed multi-
potent neural differentiation capabilities. After induction for 2
weeks under neuronal or glial cell differentiation conditions
[33], ∼80% of iNPCs expressed b-tubulin III+, a specific marker
for neuronal cells (supplemental online Fig. 3A, 3B), or S-100b,
a specific marker for Schwann cells (supplemental online Fig.
3C, 3D). The increased expression of both neuronal and Schwann
cell markers in differentiated neural cells was further confirmed
by Western blot (supplemental online Fig. 3E). Taken together,
these results suggest that 3D-spheroid culture enhances the
induction of multipotent iNPCs directly from GMSCs, with in-
creased capabilities to differentiate into neuronal and Schwann
cells.
Effects of GMSC-Derived iNPCs on Axonal Regeneration
at the Injury Site of the Rat Sciatic Nerve
To determine regenerative potential, GMSCs and their derivative
iNPCs were transplanted to the crush-injured site of rat sciatic
nerves. Our data showed that 4 weeks after transplantation,
GMSCs and iNPCs survived and engrafted at the host recipient
site, specifically confined to the epineurium without directly mi-
grating into the damaged axonal compartment (supplemental
online Fig. 4B–4E). Immunofluorescence staining demonstrated
that the transplantedGMSCsexpressedneuronalmarkerb-tubulin
III (supplemental online Fig. 4B) but not Schwann cell marker
S-100b (supplemental online Fig. 4C). However, transplanted iNPCs
expressed both b-tubulin III and S-100b (supplemental online Fig.
4D, 4E). These results suggest that iNPCs can differentiate into both
neuronal and Schwann cells in the PNS environment, thus further
confirming the multipotent property of iNPCs in vivo.
Figure 2. Conditional induction ofGMSCs into iNPCs. GMSCswere cultured in neurobasalmediumsupplementedwith 1%N-2 Supplement, 2%
B27, 20 ng/ml EGF, and 20 ng/ml bFGF under suspension culture conditions for 3 days. (A): Spheroid cells were dissociated and cultured in
polyornithine/laminin-coated 6-well plates with the same medium for 7 days. Morphological changes were observed under a microscope.
(B): Subculture ofGMSC-derived spheroid and iNPCs. Scale bars =100mm(310) (C,D): Immunofluorescence studies on theexpressionofNestin,
SOX1, PAX6, and Vimentin in GMSC-derived iNPC colonies. Nuclei were counterstained with DAPI (blue). Scale bars = 20 mm (340). (E): Per-
centageof cells positive forNestin, SOX1, PAX6, andVimentin inGMSC-derived iNPCsdeterminedby flowcytometry. (F)Westernblot analysis of
the expression of Nestin, SOX1, PAX6, and Vimentin GMSC-derived iNPCs; b-actin was used as the internal control. Abbreviations: bFGF, basic
fibroblast growth factor; DAPI, 49,6-diamidino-2-phenylindole; 3D, three-dimensional; EGF, epidermal growth factor; GMSCs, gingiva-derived
mesenchymal stem cells; iNPCs, induced neural progenitor-like cells.
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Histological examination of longitudinal sections of the sci-
atic nerves showed that the nerve fiber displayed a more orga-
nized and aligned axonal arrangement in both GMSC and iNPC
transplantation groups; in the injury control group not treated
with cells, a random pattern of axonal growth was present at
the injured site (Fig. 3C, 3D versus 3B, left panels). Of note,
the regenerative axonal pattern of the injured sciatic nerve
transplanted with iNPCs was more similar to that of the intact
normal nerve (Fig. 3C versus 3A, left panels). Immunofluores-
cence studies showed a decreased expression ofb-tubulin III in
injured nerve compared with intact normal nerve (Fig. 3B ver-
sus 3A; Fig. 3E, p , .001), which was further confirmed by
Western blot analysis (Fig. 3F). Transplantation of GMSCs
and iNPCs led to an increased expression of b-tubulin III
(Fig. 3E, 3F; Fig. 3C versus 3B, p , .001; Fig. 3D versus 3B,
p , .01); iNPCs exhibited a more pronounced effect (Fig. 3C
versus 3D; Fig. 3E, 3F, p , .05).
Because Schwann cells play a key role in successful guidance
of axonal regeneration, we examined the expression of Schwann
marker S-100b in the sciatic nerve 4 weeks after injury and cell
transplantation. In comparison with intact normal nerve, the
expression of Schwann cellmarker S-100b significantly decreased
in the injured nerve (Fig. 4B versus 4A; Fig. 4E, 4F, p , .001),
whereas transplantation of GMSCs or iNPCs significantly in-
creased S-100b expression at the injured site (Fig. 4E, 4F; Fig.
4C versus 4B, p, .01; Fig. 4D versus 4B, p, .05). Similarly, trans-
plantation of iNPCs showed more pronounced effects than
GMSCs per se to promote S-100b expression in the injured sciatic
nerve (Fig. 4E, 4F; Fig. 4C versus 4D, p, .05). Functionally, we ob-
served an overall loss of gastrocnemius musclemass in injury and
GMSC and iNPC transplantation groups at 1, 2, and 4 weeks after
injury. Fourweeks after injury, therewas no significant difference
in the averagemuscleweight betweenGMSC transplantation and
the injury groups (0.6406 0.085 versus 0.6696 0.057 g; p = .23)
Figure3. TransplantationofGMSCsand iNPCspromotedaxonal regenerationof damaged sciatic nerveof rats. A cell scaffoldproduct ofGMSCs
or GMSC-derived NPC-like cells prelabeled with PKH26 (red) and mixed with GelFoam was transplanted and wrapped around the damaged
sciatic nerve of rats. Four weeks after cell transplantation, sciatic nerves were harvested and cryosections were cut for H&E staining and im-
munofluorescence studies on the expression ofb-tubulin III protein. Normal sciatic nerve (A); injured sciatic nerve (B); injured sciatic nervewith
iNPC transplantation (C); injured sciatic nervewithGMSC transplantation (D). (E):Quantification of fluorescence integrated density ofb-tubulin
III using ImageJ. Nuclei were counterstained with DAPI (blue). Scale bars = 100mm (310) or 20mm (340). (F) Expression ofb-tubulin III protein
determined byWestern blot analysis. ppp, p, .001; pp,p, .01; p,p, .05. Abbreviations: DAPI, 49,6-diamidino-2-phenylindole; GMSC, gingiva-
derived mesenchymal stem cell; H&E, hematoxylin and eosin; iNPC, induced neural progenitor-like cell; NPC, neural progenitor-like cell.
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(Fig. 4G). However, the average muscle weight of the iNPC trans-
plantation group was slightly bulkier and heavier than that of the
injury group (0.75460.01916versus0.66960.057g,p= .04) and
GMSC transplantation group (0.754 6 0.01916 versus 0.640 6
0.085 g, p = .016), respectively (Fig. 4G).
Effects of GMSC-Derived iNPCs on Axonal Regeneration
Distal to the Injured Rat Sciatic Nerve
Because nerve injury often leads to Wallerian degeneration of
the distal segment, we studied whether GMSCs and iNPCs can
regenerate peripheral nerve distal to the injury site by examining
the expression of both b-tubulin III and S-100b. Our results
showed that transplantation ofGMSCs and iNPCs significantly im-
proved the axonal alignment of the degenerative distal nerve
ends (Fig. 5A, left panels) and increased theexpressionofb-tubulin
III compared with the injury nerve (Fig. 5A, 5B) and Western blot
analysis (Fig. 5C), respectively; the effects conferred by transplan-
tation of iNPCs were more notable than those by GMSCs (Fig. 5B,
5C; p, .05). Likewise, we observed increased S-100b expression
at thedistal segmentsof the injurednerveafter transplantationof
GMSCs and iNPCs (Fig. 5D–5F), whereby iNPC-mediated effect
Figure4. TransplantationofGMSCs and iNPCs promotedSchwann cell regeneration in thedamaged sciatic nerveof rats. A cell scaffold product
of GMSCs or GMSC-derived NPC-like cells prelabeled with PKH26 (red) and mixed with GelFoam was transplanted and wrapped around the
damaged sciatic nerve of rats. Four weeks after cell transplantation, sciatic nerves were harvested and cryosections were cut for immunoflu-
orescence studies on the protein expression of S-100b, a marker for Schwann cells. Meanwhile, gastrocnemius muscles were harvested and
weighed. Normal sciatic nerve (A); injured sciatic nerve (B); injured sciatic nerve with iNPC transplantation (C); injured sciatic nerve with GMSC
transplantation (D). Nucleiwere counterstainedwithDAPI (blue). Scale bars = 100mm(310) or 20mm(340). (E):Quantification of fluorescence
integrated density of S-100b using ImageJ. (F): Expression of S-100b protein was determined by Western blot analysis. (G): Gastrocnemius
muscle weight. ppp, p , .001; pp, p , .01; p, p , .05; #, not significant. Abbreviations: DAPI, 49,6-diamidino-2-phenylindole; GMSC,
gingiva-derived mesenchymal stem cell; iNPC, induced neural progenitor-like cell; NPC, neural progenitor-like cell.
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was stronger than that mediated by GMSCs (Fig. 5E, 5F, p, .05).
Taken together, these findings suggest that GMSC-derived NPC-
like cells possess enhanced therapeutic potential to facilitate the
repair/regeneration of injured peripheral nerves.
GMSCs and iNPCs Regulate the Expression of
Antagonistic Myelination Regulators, c-Jun and Krox-
20/EGR2, at the Injury Site of the Rat Sciatic Nerve
To further explore the potential mechanisms underlying
GMSC- and iNPC-mediated regenerative effects on injured
peripheral nerves, we examined the dynamic changes in the
expression of c-Jun and Krox-20/EGR2 proteins, two key cross-
antagonistic transcriptional regulators of dedifferentiation and
myelination of Schwann cells, respectively [38–40], in injured
rat sciatic nerves. At day 3 postinjury, the expression of c-Jun sig-
nificantly increased at the injury site; by day 7, the elevated c-Jun
started to decrease (Fig. 6A, 6B, 6I); by days 14 and 28, the levels
of c-Junwere comparable to those of normal control (Fig. 6C, 6D,
6I). However, transplantation of GMSCs or iNPCs significantly
attenuated injury-stimulated increase in c-Jun expressionwithin
7 days (Fig. 6A, 6B, 6I; p, .01), whereas iNPCs exhibited a more
pronounced inhibitoryeffect (Fig. 6A,6B,6I;p, .05atday3,p, .01
at day 7). Fourteen days postinjury, the effects of cell transplanta-
tiononc-Junexpressionwereminimal (Fig. 6C, 6D, 6I). Theseresults
suggest that GMSCs, especially GMSC-derived iNPCs, were capable
to suppress injury-triggered upregulation in the expression of the
transcription factor, c-Jun, adual functional regulator thatpositively
regulates Schwann cell dedifferentiation and negatively regulates
myelination [38–40].
We next analyzed the changes in the expression of myelin
protein P0 (P0, MPZ), which constitutes a major protein com-
ponent of myelin in the PNS. Within 2 weeks after injury, pe-
ripheral nerves underwent demyelination, as evidenced by a
sharp decrease in the expression of P0 protein (Fig. 6E–6G, 6J;
p, .001). Interestingly, the expression of P0 protein at the injured
nerve site of the GMSC and iNPC transplantation group was rela-
tively high in comparison with that in the injury control group
within 1 week postinjury (Fig. 6E, 6F, 6J; p, .05). By day 14 post-
injury, the levels of P0 protein in GMSC- and iNPC-transplanted
groups were lower than those of the injury control group (Fig.
6G,6J;p, .01). Fourweekspostinjury, theexpressionofP0protein
started to increase in injured control nerves (Fig. 6H versus 6G, sec-
ond bands; p, .05), whereas transplantation of GMSCs and iNPCs
further enhanced theexpressionofP0protein (Fig. 6H, 6J;p, .05).
Figure5. TransplantationofGMSCs/iNPCspromoted regeneration of axons andSchwann cells distal to thedamaged sciatic nerves. Fourweeks
after cell transplantation, expression ofb-tubulin III and S-100b proteins in segments of sciatic nerves distal to the damageswas determined by
immunofluorescence studies andWestern blot analysis, respectively. (A–C): Expression of b-tubulin III protein determined by immunofluores-
cence staining (A) and Western blot analysis (C); fluorescence integrated density quantified using ImageJ (B); left panel, H&E staining. (D–F):
Expression of S-100bdetermined by immunofluorescence staining (D) andWestern blot analysis (F); fluorescence integrated density quantified
using ImageJ (E). Nuclei were counterstained with DAPI (blue). Scale bars = 50mm (320). ppp, p, .001; pp, p, .01; p, p, .05. Abbreviations:
DAPI, 49,6-diamidino-2-phenylindole; GMSC, gingiva-derived mesenchymal stem cell; H&E, hematoxylin and eosin; iNPC, induced neural pro-
genitor-like cell; NPC, neural progenitor-like cell.
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Next, we analyzed the expression of Krox-20/EGR2, a major
transcription factor that governs the expression of a set of
myelination-related genes including P0 [38]. Our results showed
that transplantation of GMSCs and iNPCs consistently increased
EGR2 protein expression at all time points after nerve injury (Fig.
6E–6H, 6K; p, .05), and the overall effect of iNPCs was more no-
table than that of GMSCs (Fig. 6E, 6F, 6H; p, .05). These findings
suggest that at the early stages of peripheral nerve injury, GMSCs
and their derivative iNPCs might delay the demyelination process
and switch their functions to promote remyelination by upregulat-
ing Krox20/EGR2 protein expression at the nerve injury site.
GMSCs and iNPCs Regulate the Expression of
Antagonistic Myelination Regulators, c-Jun and Krox-
20/EGR2, at the Distal Segment of the Injured Rat
Sciatic Nerve
Our results showed that transplantation of GMSCs and their deriv-
ative iNPCs promoted axonal regeneration not only at the injury site
but also at the distal segment of the injured sciatic nerve (Fig. 5).
Mechanistically, we sought to determine the dynamic changes in
the expression of c-Jun and EGR2 protein at the distal segment of
the injured sciatic nerve after cell transplantation. Our data showed
a persistent increase in the expression of c-Jun within 14 days after
injury (Fig.7A–7C,7I;p, .001).Consistentwith theabove findingsat
the injured nerve site, transplantation of GMSCs or iNPCs signifi-
cantly attenuated the injury-stimulated increase in c-Jun expression
(Fig. 7A–7C, 7I; p , .01), and NPC-like cells also exhibited a more
pronounced inhibitory effect at the distal segment (Fig. 7A–7C, 7I;
p , .01 at day 3, p , .05 at days 7 and 14). By day 28 postinjury,
the effect of cell transplantation on c-Jun expression was minimal
(Fig. 7D, 7I). These results suggest that GMSCs, especially GMSC-
derived iNPCs, could suppress injury-triggered c-Jun upregulation
atthedistal segmentof the injuredsciaticnerve,similar totheeffects
observed at the nerve injury site.
We then analyzed the changes in the expression of myelin
protein P0 and the transcription factor Krox20/EGR2 at the distal
segment of the injured nerve. Similar to the expression pattern of
Figure 6. Effects of GMSC/iNPC transplantation on the expression of c-Jun and Krox-20/EGR2 in damaged sciatic nerves. At different time
points after nerve injury and cell transplantation, sciatic nerves were harvested and tissue lysates were prepared for Western blot analysis.
(A–D): Transplantation of GMSCs and iNPCs suppressed injury-triggered upregulation of c-Jun protein within 7 days after injury. (E–H): Effects
of GMSC and iNPC transplantation on the expression of Krox-20/EGR2 and the myelin protein P0. (I): Graphs show dynamic changes in the
expression of c-Jun protein summarized from Western blot analysis in Fig. 6A–6D. (J,K): Graphs show dynamic changes in the expression of
P0 (J) and Krox-20/EGR2 (K) proteins summarized from Western blot analysis in Fig. 6E–6H. ppp, p, .001; pp, p, .01; p, p, .05; #, not sig-
nificant. Abbreviations: Con, control; GMSC, gingiva-derived mesenchymal stem cell; iNPC, induced neural progenitor-like cell.
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P0 protein at the injury site, a sharp decrease in the expression of
this myelin protein was continuously observed at the distal seg-
ment of the injured nerve until day 14 postinjury (Fig. 7E–7G, 7J;
p, .001); the injury-induceddecrease inP0proteinexpressionwas
attenuated in the GMSC and iNPC transplantation groups within 1
week postinjury (Fig. 7E, 7F, 7J; p, .05). By day 14 postinjury, the
expression of P0 protein in the injury control and GMSC- and
iNPC-transplanted groups declined to a level thatwas almost un-
detectable (Fig. 7G, 7J). Fourweeks postinjury, the expression of
P0 protein started to increase in injured control nerves (Fig. 7H
versus 7G, second bands; p , .05), whereas transplantation of
GMSCs and iNPCs further enhanced its expression (Fig. 7H; p,
.05). Similar to our findings of Krox20/EGR2 protein expression
at the injury sites, transplantation of GMSCs and iNPCs consis-
tently increased EGR2 protein expression at all time points after
nerve injury (Fig. 7E–7H, 7K; p, .01), and iNPCs exhibited a more
pronounced overall effect than GMSCs (Fig. 7E, 7G, p, .05; Fig.
7H, p, .01). Taken together, consistent with findings at the injury
site, GMSCs and their derivative iNPCs might delay the demyelin-
ation process and subsequently switch to promote remyelination
at the early stages of peripheral nerve injury, by upregulating
Krox20/EGR2 expression at the distal segment of the injured
nerve.
DISCUSSION
Multipotent MSCs possess potent anti-inflammatory and immu-
nomodulatory functions and paracrine trophic effects on tissue
repair [47, 48]. These unique pleiotropic properties ofMSCs have
made themgoodcandidates for anallogeneic cell source in regen-
erative medicine. Accumulating evidence has implied that MSCs
derived from tissues [9–11], particularly from dental pulp [20, 49,
50], confer beneficial effects on peripheral nerve regeneration.
Mechanistically, MSC-mediated beneficial effects on peripheral
nerve regeneration havemultiple facets, whichmay involve their
multipotent transdifferentiation into different lineages of neuro-
nal andglial cells (particularly regenerative Schwanncells) [14, 15,
19, 21], their paracrine neurotrophic [12, 20, 22] and proangio-
genic [12, 16, 17] effects, and their immunomodulatory/ anti-
inflammatory and antifibrosis properties [11, 16]. However, the
Figure 7. Effects of GMSC/iNPC transplantation on the expression of c-Jun and Krox-20/EGR2 in the distal segments of damaged sciatic nerves.
At different time points after nerve injury and cell transplantation, distal segments of sciatic nerves were harvested and tissue lysates were
prepared forWesternblot analysis. (A–D):TransplantationofGMSCsand iNPCs suppressed injury-triggeredupregulationof c-Junproteinwithin
14 days after injury. (E–H): Effects of GMSC and iNPC transplantation on the expression of Krox-20/EGR2 and the myelin protein P0. (I): Graphs
show dynamic changes in the expression of c-Jun protein summarized from Western blot analysis in Fig. 6A–6D. (J,K): Graphs show dy-
namic changes in the expression of P0 (J) and Krox-20/EGR2 (K) proteins summarized from Western blot analysis in Fig. 6E–6H. ppp, p, .001;
pp, p, .01; p, p, .05; #, not significant. Abbreviations: Con, control; GMSC, gingiva-derived mesenchymal stem cell; iNPC, induced neural pro-
genitor-like cell.
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high heterogeneity, variable neural differentiation and survival
abilities, and suboptimal clinical outcomes may constitute signif-
icant hurdles for the clinical application of MSCs in peripheral
nerve regeneration.
Adult neural stem cells represent a unique subpopulation of
self-renewing andmultipotent neural progenitor cells [51] with in-
herent potential to differentiate into all types of neural cells, such
as neurons, astrocytes, and oligodendrocytes. Numerous preclini-
cal andclinical studieshavedemonstrated thepromisingefficacyof
NSC-based therapy to improve the functional recoveryof damaged
neural tissues under various neuropathological settings [51–53].
However, difficulties in the isolation and in vitro expansion of NSCs
have significantly blocked their clinical application. Most recently,
several lines of evidence have demonstrated that introduction of
defined setsof specific transcription factors can directly reprogram
or convert differentiated somatic cells, e.g., fibroblasts, into prolif-
erative and multipotent neural stem/progenitors [24–26, 28]. In-
terestingly, Ring et al. [27] recently reported that self-renewable
and multipotent induced NSCs without tumorigenic potential
can be generated directly from mouse and human fibroblasts
reprogrammed with a single factor, SOX2, and Kim et al. [29] re-
ported that human fibroblasts could be directly reprogrammed
into induced neural crest cells by overexpression of a single tran-
scription factor, SOX10, in combination with environmental cues,
such as WNT activation. Of note, direct conversion of somatic dif-
ferentiated cells to iNSCs/iNPCs by introducing exogenous factors
raises clinical safety concerns, similar to iPSC technology.
Most recently, studies have demonstrated the generation of
NPC-like cells from both mouse and human somatic cells using
only a cocktail of small-molecule compounds, without the intro-
duction of exogenous transcription factors [34]. These small-
molecule compounds induce conversion toward a neural fate
by inhibition of histone deacetylases, transforming growth fac-
tor-b, and glycogen synthase kinase 3, which is accompanied
by the activation of Sox2, a transcription factor that can convert
somatic cells into NPCs [27]. Meanwhile, NPCs can be induced
directly from human adipose stem cells and human and mouse
fibroblasts by simply culturing under special conditions, e.g., sus-
pension 3D-spheroid culture [11, 31, 32], or in defined culture
media [33]. The minimally manipulated approach using only
small-molecule compounds, defined culture conditions, or a com-
binationof bothwithout exogenous gene introductionpromises a
safer strategy for the generation of expandable and multipotent
NPCs directly from somatic cells for autologous cell-based ther-
apy of neurological disorders [54].
In the present study, we show for the first time that GMSCs
can be directly induced to multipotent and expandable NPC-like
cells through nongenetic approaches, and these iNPCs exhibited
significantly increased secretion of the neurotrophic factor GDNF
and the proangiogenic factor VEGF. More importantly, these
GMSC-derived iNPCs, after direct transplantation to the crush
injury site of rat sciatic nerve, could differentiate into both neu-
ronal and Schwann cells and exhibited potential therapeutic ef-
fects by promoting axonal regeneration at both the injury site
and the distal segment of the injured nerve. In addition, we ob-
served that transplanted GMSCs and iNPCs did not penetrate
the epineurium, nor did they directly migrate to the damaged ax-
onal compartment, suggesting that transplantationofGMSCsand
iNPCs probably promote regeneration of injured nerves through
their paracrine neurotrophic and proangiogenic effects. Because
of their easily accessible and highly proliferative properties,
neural crest origin, multipotency toward different neural line-
ages, and direct conversion of NPC-like cells, GMSCs potentially
serve as a superior seed cell source for autologous and/or alloge-
neic stemcell-based therapy for PNI. Future studies are necessary
to further explore whether cell context-dependent induction of
iNPCs requires distinctmechanisms and how to optimize the con-
ditions to obtain adequate numbers of transplantable iNPCs in a
timely manner.
In response to PNI, Schwann cells undergo reprogramming
or dedifferentiation into immature precursor or progenitor-like
states [55–57], whereas myelinating Schwann cells cease to ex-
press myelin protein by downregulating the expression of
Krox20/EGR2, a key transcription factor that governs myelin pro-
tein expression, while upregulating the expression of negative
regulators of myelination such as the transcription factor c-Jun
[37–39]. Therefore, regulation of the expression of the antagonis-
tic c-Jun and Krox20/EGR2 transcription factors involved in the
dedifferentiation and myelination processes of Schwann cells
represents a novel approach to optimize peripheral nerve regen-
eration. In the present study, we demonstrated for the first time
to our knowledge that perineural transplantation of GMSCs, par-
ticularly GMSC-derived iNPCs, could significantly suppress injury-
triggered increase of c-Jun expression at both the injury site and
the distal segment of the injured nervewithin 1week after injury.
Meanwhile, we showed that transplantation of GMSCs and iNPCs
upregulated the expression of themyelination regulator, Krox20/
EGR2protein, at both the injury site and thedistal segmentduring
nerve repair/regeneration. These findings suggest that GMSCs
and iNPCs promote peripheral nerve repair/regeneration possi-
bly by regulating both dedifferentiation and remyelination of
Schwann cells in injured nerves. However, it is noteworthy that
c-Jun, in addition to its role as a negative regulator of myelination
[39, 58], plays a central role in controlling both components of the
Schwann cell reprogramming, dedifferentiation, and activation of
the repair program, including the expression of trophic factors,
adhesionmolecules, formation of regeneration track, andmyelin
clearance [40, 58]. Reduced activation of c-Jun has been impli-
cated in the formation of dysfunctional repair Schwann cells
[40] and age-dependent reduction in nerve regeneration [59].
Therefore, further studies are warranted to identify the soluble
factors and corresponding signaling pathways involved in GMSC-
and iNPC-mediated regulation of Schwann cell dedifferentiation
and myelination.
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